A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
about
The Natural Course of Non-Alcoholic Fatty Liver DiseaseNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Cardiovascular dysfunction in patients with liver cirrhosisNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Nonalcoholic fatty liver disease - A multisystem disease?Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVEmerging risk biomarkers in cardiovascular diseases and disordersCauses of changes in carotid intima-media thickness: a literature reviewNon-alcoholic fatty liver disease and cardiovascular risk.Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshopNonalcoholic fatty liver disease and aging: epidemiology to management.Is serum Interleukin-17 associated with early atherosclerosis in obese patients?Hepatokines as a Link between Obesity and Cardiovascular Diseases.Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c.Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study.Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal womenFatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortalityIn Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter.Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival.Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver diseaseNonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients.Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study.Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD.Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease.Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease - current status and future directions.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1.Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease.Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test.
P2860
Q26746947-E5A9D195-3083-44FA-9B70-9F825AE47E53Q26750955-76377432-D220-492D-8BF3-C087242A3836Q27010592-0E08ABD6-05FC-49CD-965E-1E2D0CACB357Q27692035-F052359B-73F9-412E-AC2B-0751CE78F224Q28079077-DB88F150-06CB-41CC-96FB-A0B060878EE8Q28079826-0EA31FFD-B782-47A9-B46C-FF933BB023C6Q28081614-33A2C235-DB9B-4D28-ACCD-87641CD0E97DQ28085227-99F440F8-8A0F-48C6-9648-40C74F241469Q33706265-5C1AF6D5-2F16-405B-9B04-4AEDDACE63BFQ33791133-D5B8467E-4C75-49D9-8380-C1299C986473Q34366861-2F4E8284-6137-4DF1-AE2E-80198304DF4AQ34635257-D9CC66A4-EDEE-4625-8601-BDA8D3219335Q35126823-43A143A0-45AA-4862-9649-162A67207907Q35258097-93671711-9164-4881-A35D-23E289192618Q35670773-B3708D10-1B75-4028-B232-B43B5FAEE1D6Q35683422-7251819D-61C6-4DAE-A9EE-5CB2C415B730Q35855651-13F61301-57A6-4835-B2A3-FB1069680867Q35903742-32E366EC-A63B-4766-AA57-E234EC0AC696Q35926253-A74BD6C2-FB4F-48B8-BDC7-FE0B2736D7B6Q36336631-A5E67CD9-7DFE-4FEB-9E10-2CAB7082DBA0Q36401621-4344C40E-1848-4830-B4F9-2207EA72EEC0Q36581177-3DD8A1F8-4AD8-4E62-8913-9FD157D5B37AQ36656294-BEDDF3DF-51FA-497D-B5AF-6A71CAB3107AQ36673799-3B44CD93-F859-4D16-A84B-E799356C6CA8Q36769687-B06DA1AF-4719-4FEA-9A91-CCCF620C19A4Q36937278-84983EBC-EFD1-45D6-9494-968CA85562F1Q36952218-897F32E8-DF38-4D21-9474-0D6EC51548B4Q36978865-C70E84E5-EE64-4E3F-8503-337711AF7C2AQ37057956-7BB9DB47-F519-412A-97DE-7700DC346DDFQ37615518-69D17A4E-5191-4AB9-9E86-DDBE12B0BB58Q37664577-1AF74BD2-5022-46CF-B43B-786F7E4112DCQ38261236-CF888FCA-6700-4308-AA91-518322776475Q38592767-ADBA5FEA-83A0-4569-BF42-82AA22A56805Q38676257-448FAD9F-1F92-480B-9308-C56149E8D083Q38711424-9EEA45CD-3614-4685-899E-56534940E2BBQ38915869-AF576304-DCE4-45BC-9A55-ED54AD1908DDQ39105659-0CD4BE04-7352-416B-9024-CBBEE55905B4Q39377977-CE0C8A40-7803-4AA3-9208-35372D5C8B7CQ39692793-6CED38AF-E4E8-4374-9712-F28F500F25E1Q40080468-20054656-B866-490A-A377-9596A1E7D309
P2860
A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A systematic review: burden an ...... c fatty liver; should we care?
@ast
A systematic review: burden an ...... c fatty liver; should we care?
@en
type
label
A systematic review: burden an ...... c fatty liver; should we care?
@ast
A systematic review: burden an ...... c fatty liver; should we care?
@en
prefLabel
A systematic review: burden an ...... c fatty liver; should we care?
@ast
A systematic review: burden an ...... c fatty liver; should we care?
@en
P2093
P50
P1433
P1476
A systematic review: burden an ...... c fatty liver; should we care?
@en
P2093
Arthur S Agatston
Ebenezer T Oni
Jonathan Fialkow
Michael J Blaha
Raul D Santos
Ricardo Cury
Ron Blankstein
Ted Feldman
P304
P356
10.1016/J.ATHEROSCLEROSIS.2013.07.052
P577
2013-08-09T00:00:00Z